Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Beenken

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|December 4, 2019
Not all proteinuria is created equalAndrew Beenken, Jonathan M Barasch, Ali G Gharavi
Structure (London, England : 1993)|August 1, 2017
Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory HomodimerizationYang Liu, Jinghong Ma, Andrew Beenken, et al.
The Journal of Biological Chemistry|November 8, 2011
Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1Andrew Beenken, Anna V Eliseenkova, Omar A Ibrahimi, et al.
Biochemistry|July 14, 2009
Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexesFuming Zhang, Zhenqing Zhang, Xinfu Lin, et al.
Glomerular Diseases|June 12, 2025
Familial Idiopathic Glomerular Disease due to a Unique Renal-Predominant Phenotype of MYH9-Related Disease: A Case ReportNatasha S Freeman, Kelsie Bogyo, Andrew Beenken, et al.
Structure (London, England : 1993)|January 17, 2012
The alternatively spliced acid box region plays a key role in FGF receptor autoinhibitionJuliya Kalinina, Kaushik Dutta, Dariush Ilghari, et al.
Science Signaling|September 17, 2009
Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesisHelen P Makarenkova, Matthew P Hoffman, Andrew Beenken, et al.
Cardiovascular Research|October 11, 2017
A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administrationChahua Huang, Yang Liu, Andrew Beenken, et al.
Cell|February 7, 2023
Structures of LRP2 reveal a molecular machine for endocytosisAndrew Beenken, Gabriele Cerutti, Julia Brasch, et al.
Journal of Proteome Research|April 20, 2026
Proximity Labeling Reveals How Lrp2 Interacts with the Endocytic MachineTian H Shen, Andrew Beenken, Hediye Erdjument-Bromage, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|December 4, 2019
Not all proteinuria is created equalAndrew Beenken, Jonathan M Barasch, Ali G Gharavi
Structure (London, England : 1993)|August 1, 2017
Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory HomodimerizationYang Liu, Jinghong Ma, Andrew Beenken, et al.
The Journal of Biological Chemistry|November 8, 2011
Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1Andrew Beenken, Anna V Eliseenkova, Omar A Ibrahimi, et al.
Biochemistry|July 14, 2009
Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexesFuming Zhang, Zhenqing Zhang, Xinfu Lin, et al.
Glomerular Diseases|June 12, 2025
Familial Idiopathic Glomerular Disease due to a Unique Renal-Predominant Phenotype of MYH9-Related Disease: A Case ReportNatasha S Freeman, Kelsie Bogyo, Andrew Beenken, et al.
Structure (London, England : 1993)|January 17, 2012
The alternatively spliced acid box region plays a key role in FGF receptor autoinhibitionJuliya Kalinina, Kaushik Dutta, Dariush Ilghari, et al.
Science Signaling|September 17, 2009
Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesisHelen P Makarenkova, Matthew P Hoffman, Andrew Beenken, et al.
Cardiovascular Research|October 11, 2017
A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administrationChahua Huang, Yang Liu, Andrew Beenken, et al.
Cell|February 7, 2023
Structures of LRP2 reveal a molecular machine for endocytosisAndrew Beenken, Gabriele Cerutti, Julia Brasch, et al.
Journal of Proteome Research|April 20, 2026
Proximity Labeling Reveals How Lrp2 Interacts with the Endocytic MachineTian H Shen, Andrew Beenken, Hediye Erdjument-Bromage, et al.
Pageof 4